July 21, 2025: World’s First Hemato-Oncology Microbiota Therapeutic Among Latest New EU Filings - Citeline - MaaT Pharma

To read the article, click here!

Previous PostJuly 24, 2025: MaaT Pharma: Half-year Report to the Liquidity Contract With Kepler Cheuvreux
Next PostJuly 7, 2025: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club